share_log

United States Cellular Analyst Ratings

United States Cellular Analyst Ratings

美國蜂窩分析師評級
Benzinga ·  2023/08/09 11:13
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
08/09/2023 0.26% Wells Fargo $16 → $38 Upgrades Underweight → Equal-Weight
08/08/2023 JP Morgan Upgrades Neutral → Overweight
07/26/2023 -28.76% Morgan Stanley $26 → $27 Maintains Equal-Weight
07/25/2023 -28.76% Morgan Stanley $26 → $27 Maintains Equal-Weight
05/08/2023 -57.78% Wells Fargo $22 → $16 Maintains Underweight
02/07/2023 -36.68% Morgan Stanley $37 → $24 Maintains Equal-Weight
01/10/2023 -47.23% Wells Fargo $33 → $20 Downgrades Overweight → Underweight
11/08/2022 -36.68% JP Morgan $32 → $24 Upgrades Underweight → Neutral
11/07/2022 Raymond James Downgrades Strong Buy → Market Perform
08/08/2022 2.9% Raymond James $41 → $39 Maintains Strong Buy
05/09/2022 8.18% Raymond James $40 → $41 Maintains Strong Buy
04/19/2022 -2.37% Morgan Stanley → $37 Downgrades Overweight → Equal-Weight
02/22/2022 -12.93% Wells Fargo $36 → $33 Maintains Overweight
02/22/2022 5.54% Raymond James $43 → $40 Maintains Strong Buy
08/02/2021 -5.01% JP Morgan $35 → $36 Downgrades Neutral → Underweight
07/22/2021 31.93% Morgan Stanley $50.5 → $50 Maintains Overweight
02/22/2021 -7.65% JP Morgan $42 → $35 Downgrades Overweight → Neutral
01/14/2021 33.25% Morgan Stanley $57 → $50.5 Maintains Overweight
11/16/2020 -5.01% Wells Fargo → $36 Reinstates → Overweight
08/31/2020 21.37% Citigroup $45 → $46 Maintains Buy
08/27/2020 50.4% Morgan Stanley $56 → $57 Maintains Overweight
08/10/2020 13.46% Raymond James $40 → $43 Maintains Strong Buy
07/08/2020 47.76% Morgan Stanley $57 → $56 Maintains Overweight
05/18/2020 5.54% Raymond James $39 → $40 Reiterates → Strong Buy
05/14/2020 -10.29% B. Riley Securities $42 → $34 Maintains Neutral
04/22/2020 2.9% Raymond James $41 → $39 Maintains Strong Buy
04/09/2020 50.4% Morgan Stanley $63 → $57 Maintains Overweight
03/27/2020 10.82% JP Morgan $45 → $42 Maintains Overweight
03/02/2020 66.23% Citigroup $66 → $63 Maintains Buy
11/04/2019 29.29% Raymond James $53 → $49 Upgrades Outperform → Strong Buy
11/04/2019 18.73% JP Morgan → $45 Upgrades Neutral → Overweight
08/06/2019 5.54% Wells Fargo $50 → $40 Maintains Market Perform
08/06/2019 10.82% B. Riley Securities $50 → $42 Maintains Neutral
08/05/2019 21.37% JP Morgan → $46 Upgrades Underweight → Neutral
06/18/2019 70.18% Morgan Stanley $44 → $64.5 Upgrades Equal-Weight → Overweight
05/06/2019 39.84% Raymond James $56 → $53 Reiterates → Outperform
11/06/2018 47.76% Raymond James $43 → $56 Maintains Outperform
日期 上行/下行 分析公司 目標價格變化 評級變化 上一次/當前評級
08/09/2023 0.26% 富國銀行 $16→$38 升級 重量不足的→等重
2023/08/08 - 摩根大通 升級 中性→超重
07/26/2023 -28.76% 摩根士丹利 $26→$27 維護 等重
07/25/2023 -28.76% 摩根士丹利 $26→$27 維護 等重
05/08/2023 -57.78% 富國銀行 $22→$16 維護 體重不足
02/07/2023 -36.68% 摩根士丹利 $37→$24 維護 等重
2023年1月10日 -47.23% 富國銀行 $33→$20 評級下調 增持→減持
11/08/2022 -36.68% 摩根大通 $32→$24 升級 減重→中性
11/07/2022 - 雷蒙德·詹姆斯 評級下調 強勁的購買→市場表現
2022/08/08 2.9% 雷蒙德·詹姆斯 $41→$39 維護 強勢購買
05/09/2022 8.18% 雷蒙德·詹姆斯 $40→$41 維護 強勢購買
04/19/2022 -2.37% 摩根士丹利 →$37 評級下調 超重→等重
02/22/2022 -12.93% 富國銀行 $36→$33 維護 超重
02/22/2022 5.54% 雷蒙德·詹姆斯 $43→$40 維護 強勢購買
08/02/2021 -5.01% 摩根大通 $35→$36 評級下調 中性→減持
07/22/2021 31.93% 摩根士丹利 $50.5→$50 維護 超重
02/22/2021 -7.65% 摩根大通 $42→$35 評級下調 超重→中性
2021/01/14 33.25% 摩根士丹利 $57→$50.5 維護 超重
11/16/2020 -5.01% 富國銀行 →$36 恢復 →超重
08/31/2020 21.37% 花旗集團 $45→$46 維護
2020/08/27 50.4% 摩根士丹利 $56→$57 維護 超重
2020/08/10 13.46% 雷蒙德·詹姆斯 $40→$43 維護 強勢購買
07/08/2020 47.76% 摩根士丹利 $57→$56 維護 超重
05/18/2020 5.54% 雷蒙德·詹姆斯 $39→$40 重申 →強勢購買
2020/05/14 -10.29% B.萊利證券 $42→$34 維護 中性
04/22/2020 2.9% 雷蒙德·詹姆斯 $41→$39 維護 強勢購買
04/09/2020 50.4% 摩根士丹利 $63→$57 維護 超重
03/27/2020 10.82% 摩根大通 $45→$42 維護 超重
03/02/2020 66.23% 花旗集團 $66→$63 維護
2019/11/04 29.29% 雷蒙德·詹姆斯 $53→$49 升級 跑贏→強勢買入
2019/11/04 18.73% 摩根大通 →$45 升級 中性→超重
2019年08月06日 5.54% 富國銀行 $50→$40 維護 市場表現
2019年08月06日 10.82% B.萊利證券 $50→$42 維護 中性
2019年08月05日 21.37% 摩根大通 →$46 升級 減重→中性
2019年06月18日 70.18% 摩根士丹利 $44→$64.5 升級 等重→超重
2019年05月06日 39.84% 雷蒙德·詹姆斯 $56→$53 重申 →跑贏大盤
2018/06/11 47.76% 雷蒙德·詹姆斯 $43→$56 維護 跑贏大盤

What is the target price for United States Cellular (USM)?

美國蜂窩(USM)的目標價是多少?

The latest price target for United States Cellular (NYSE: USM) was reported by Wells Fargo on August 9, 2023. The analyst firm set a price target for $38.00 expecting USM to rise to within 12 months (a possible 0.26% upside). 9 analyst firms have reported ratings in the last year.

富國銀行於2023年8月9日報道了美國蜂窩(紐約證券交易所代碼:USM)的最新目標價。這家分析公司將目標價定為38.00美元,預計USM將在12個月內上漲至0.26%(可能上漲0.26%)。去年有9家分析公司公佈了評級。

What is the most recent analyst rating for United States Cellular (USM)?

美國蜂窩(USM)的最新分析師評級是多少?

The latest analyst rating for United States Cellular (NYSE: USM) was provided by Wells Fargo, and United States Cellular upgraded their equal-weight rating.

美國細胞公司(紐約證券交易所代碼:USM)的最新分析師評級由富國銀行提供,美國細胞公司上調了其同等權重的評級。

When is the next analyst rating going to be posted or updated for United States Cellular (USM)?

美國蜂窩(USM)的下一次分析師評級將於何時發佈或更新?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of United States Cellular, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for United States Cellular was filed on August 9, 2023 so you should expect the next rating to be made available sometime around August 9, 2024.

分析師在進行了廣泛的研究後得出了股票評級,這些研究包括查閱公共財務報表,與United States Ccell的高管和客戶交談,以及收聽收益電話會議。大多數分析師每三個月就會這樣做一次,所以你每年應該會得到每家公司每家公司的4個評級。美國蜂窩的上一次評級是在2023年8月9日提交的,所以你應該預計下一次評級將在2024年8月9日左右提供。

Is the Analyst Rating United States Cellular (USM) correct?

分析師對美國蜂窩(USM)的評級正確嗎?

While ratings are subjective and will change, the latest United States Cellular (USM) rating was a upgraded with a price target of $16.00 to $38.00. The current price United States Cellular (USM) is trading at is $37.90, which is within the analyst's predicted range.

雖然評級是主觀的,並將發生變化,但最新的美國蜂窩(USM)評級被上調,目標價為16.00美元至38.00美元。目前美國行動電話(USM)的交易價格為37.90美元,在分析師的預測範圍內。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論